[go: up one dir, main page]

AU2001268526A1 - Multiple phase cross-linked compositions and uses thereof - Google Patents

Multiple phase cross-linked compositions and uses thereof

Info

Publication number
AU2001268526A1
AU2001268526A1 AU2001268526A AU6852601A AU2001268526A1 AU 2001268526 A1 AU2001268526 A1 AU 2001268526A1 AU 2001268526 A AU2001268526 A AU 2001268526A AU 6852601 A AU6852601 A AU 6852601A AU 2001268526 A1 AU2001268526 A1 AU 2001268526A1
Authority
AU
Australia
Prior art keywords
multiple phase
phase cross
linked compositions
linked
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268526A
Inventor
Bo Qiu
Stanley Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers Health
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of AU2001268526A1 publication Critical patent/AU2001268526A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2001268526A 2000-06-19 2001-06-19 Multiple phase cross-linked compositions and uses thereof Abandoned AU2001268526A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21251100P 2000-06-19 2000-06-19
US60/212,511 2000-06-19
US09/883,842 US20020076443A1 (en) 2000-06-19 2001-06-18 Multiple phase cross-linked compositions and uses thereof
US09/883,842 2001-06-18
PCT/US2001/019451 WO2001097865A2 (en) 2000-06-19 2001-06-19 Multiple phase cross-linked compositions and uses thereof

Publications (1)

Publication Number Publication Date
AU2001268526A1 true AU2001268526A1 (en) 2002-01-02

Family

ID=26907207

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268526A Abandoned AU2001268526A1 (en) 2000-06-19 2001-06-19 Multiple phase cross-linked compositions and uses thereof

Country Status (3)

Country Link
US (3) US20020076443A1 (en)
AU (1) AU2001268526A1 (en)
WO (1) WO2001097865A2 (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003031483A1 (en) 2001-10-10 2003-04-17 The Regents Of The University Of Colorado Degradable thiol-ene polymers
GB0307011D0 (en) * 2003-03-27 2003-04-30 Regentec Ltd Porous matrix
US9694103B2 (en) 2003-04-16 2017-07-04 The Children's Hospital Of Philadelphia Photochemical activation of surfaces for attaching biomaterial
US7635734B2 (en) * 2004-02-17 2009-12-22 The Children's Hospital Of Philadelphia Photochemical activation of surfaces for attaching biomaterial
CN101031288B (en) * 2004-10-01 2010-11-03 普罗米蒂克生物科学公司 Medium-chain length fatty alcohols as hematopoiesis stimulating agents
US8071580B2 (en) * 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
WO2008133918A1 (en) * 2007-04-24 2008-11-06 Rutgers, The State University Of New Jersey Dressing compositions and methods
BRPI0611272A2 (en) * 2005-05-03 2011-11-16 Mutual Pharmaceutical Co quinine formulations
AR064286A1 (en) 2006-12-13 2009-03-25 Quiceno Gomez Alexandra Lorena PRODUCTION OF OPHTHALMIC DEVICES BASED ON POLYMERIZATION BY PHOTOINDUCIDED SCALE GROWTH
DE102007034580B4 (en) * 2007-07-13 2012-11-08 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Biomaterial based on a hydrophilic polymeric carrier
CA2720474A1 (en) * 2008-04-04 2009-10-08 Rutgers University Nanocarrier and nanogel compositions
CA2722743A1 (en) * 2008-04-28 2009-11-05 Zogenix, Inc. Novel formulations for treatment of migraine
EP2408372B1 (en) 2009-03-02 2019-01-09 Seventh Sense Biosystems, Inc. Devices associated with blood sampling
WO2012018486A2 (en) 2010-07-26 2012-02-09 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
US8685458B2 (en) 2009-03-05 2014-04-01 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives
US20110150986A1 (en) * 2009-12-18 2011-06-23 Kristin Arnold Quinine formulations, method of making, and metho of use thereof
US20120039809A1 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
US8808202B2 (en) 2010-11-09 2014-08-19 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
GB201101429D0 (en) * 2011-01-27 2011-03-16 Biocompatibles Uk Ltd Drug delivery system
WO2012103445A2 (en) 2011-01-28 2012-08-02 The Regents Of The University Of Colorado, A Body Corporate Convalently cross linked hydrogels and methods of making and using same
WO2012149134A1 (en) 2011-04-29 2012-11-01 Seventh Sense Biosystems, Inc. Devices and methods for collection and/or manipulation of blood spots or other bodily fluids
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
EP2701598A1 (en) 2011-04-29 2014-03-05 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
JP6121400B2 (en) 2011-04-29 2017-04-26 セブンス センス バイオシステムズ，インコーポレーテッド Delivery and / or receipt of fluid
US9084727B2 (en) 2011-05-10 2015-07-21 Bend Research, Inc. Methods and compositions for maintaining active agents in intra-articular spaces
US9988433B2 (en) 2013-03-14 2018-06-05 Mosaic Biosciences, Inc. Covalent modification of biological macromolecules
EP2822533B1 (en) 2012-02-02 2021-01-20 Mosaic Biosciences, Inc. Biomaterials for delivery of blood extracts and methods of using same
WO2014039799A2 (en) * 2012-09-07 2014-03-13 The Children's Hospital Of Philadelphia Photochemical activation of surfaces for attaching biomaterial
CN102898661B (en) * 2012-10-17 2014-01-08 浙江大学 Polyethylene glycol hydrogel for orthotopic injection and preparation method thereof
EP2961733B1 (en) * 2013-02-28 2021-01-13 Tufts University Disulfide compounds for delivery of pharmaceutical agents
WO2014186185A1 (en) * 2013-05-14 2014-11-20 Dow Global Technologies Llc Cellulose ethers esterified with dicarboxylic acids
CN103705943B (en) * 2014-01-03 2016-09-14 北京大学 A kind of preparation reducing response type pegylated medicament nano-composition and application thereof
EP3256167B1 (en) 2015-02-09 2020-11-11 Mosaic Biosciences, Inc. Degradable thiol-ene polymers and methods of making thereof
CA3031467A1 (en) 2016-07-26 2018-02-01 Vivek Anand PARACHUR Slow release composition of active ingredients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69028767T2 (en) * 1989-10-19 1997-03-20 Shiseido Co Ltd HYDROPHILIC POLYMERSILICATE MINERAL COMPOSITE MATERIAL AND ITS USE
US5716644A (en) * 1992-06-11 1998-02-10 Alkermes, Inc. Composition for sustained release of non-aggregated erythropoietin
NZ262679A (en) * 1993-02-22 1997-08-22 Vivorx Pharmaceuticals Inc Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
US5840338A (en) * 1994-07-18 1998-11-24 Roos; Eric J. Loading of biologically active solutes into polymer gels
US5540853A (en) * 1994-10-20 1996-07-30 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US6565842B1 (en) * 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions
DK2111876T3 (en) * 1995-12-18 2011-12-12 Angiodevice Internat Gmbh Crosslinked polymer preparations and methods for their use
US6312725B1 (en) * 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
WO2000078285A1 (en) * 1999-06-18 2000-12-28 University Of Medicine And Dentistry Of New Jersey Controlled release of therapeutics by in-situ entrapment by matrix cross-linking

Also Published As

Publication number Publication date
WO2001097865A2 (en) 2001-12-27
US20060204582A1 (en) 2006-09-14
WO2001097865A3 (en) 2003-03-27
US20020076443A1 (en) 2002-06-20
US20110135732A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
AU2001268526A1 (en) Multiple phase cross-linked compositions and uses thereof
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU2001282877A1 (en) Cosmetic compositions
AU2473401A (en) Organosiloxane compositions
AU4546800A (en) Hair conditioning compositions
AU3976200A (en) Cosmetic compositions
AU2001265919A1 (en) Cosmetic compositions
AU2001293728A1 (en) Cosmetic composition
AUPQ875700A0 (en) Combination compositions
AU2001267394A1 (en) Rinse-off cosmetic conditioning compositions
AU2001241098A1 (en) Composition
AU1152601A (en) Compositions and their use
AU2000270997A1 (en) Pre-shampoo conditioning composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001256202A1 (en) Cosmetic compositions
AU2001259252A1 (en) Neuroprotective compositions
AU2001275201A1 (en) Acne-treating composition
AU2000274826A1 (en) Cosmetic compositions
AU2001235764A1 (en) Compositions
AU2001287852A1 (en) Composition
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU3869099A (en) Hair conditioning compositions
AU2001232075A1 (en) Compound, composition and use
AU2001232080A1 (en) Compound, compositions and use
AU2002227928A1 (en) Cosmetic composition